These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Preventing the second episode: a systematic review and meta-analysis of psychosocial and pharmacological trials in first-episode psychosis. Alvarez-Jiménez M; Parker AG; Hetrick SE; McGorry PD; Gleeson JF Schizophr Bull; 2011 May; 37(3):619-30. PubMed ID: 19900962 [TBL] [Abstract][Full Text] [Related]
9. To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: HAMLETT, a pragmatic multicenter single-blind randomized controlled trial. Begemann MJH; Thompson IA; Veling W; Gangadin SS; Geraets CNW; van 't Hag E; Müller-Kuperus SJ; Oomen PP; Voppel AE; van der Gaag M; Kikkert MJ; Van Os J; Smit HFE; Knegtering RH; Wiersma S; Stouten LH; Gijsman HJ; Wunderink L; Staring ABP; Veerman SRT; Mahabir AGS; Kurkamp J; Pijnenborg GHM; Veen ND; Marcelis M; Grootens KP; Faber G; van Beveren NJ; Been A; van den Brink T; Bak M; van Amelsvoort TAMJ; Ruissen A; Blanke C; Groen K; de Haan L; Sommer IEC Trials; 2020 Feb; 21(1):147. PubMed ID: 32033579 [TBL] [Abstract][Full Text] [Related]
10. Long-acting antipsychotic medication as first-line treatment of first-episode psychosis with comorbid substance use disorder. Abdel-Baki A; Thibault D; Medrano S; Stip E; Ladouceur M; Tahir R; Potvin S Early Interv Psychiatry; 2020 Feb; 14(1):69-79. PubMed ID: 31125513 [TBL] [Abstract][Full Text] [Related]
11. Long-term outcomes of antipsychotic treatment in patients with first-episode schizophrenia: a systematic review. Karson C; Duffy RA; Eramo A; Nylander AG; Offord SJ Neuropsychiatr Dis Treat; 2016; 12():57-67. PubMed ID: 26792993 [TBL] [Abstract][Full Text] [Related]
12. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation]. Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I Encephale; 2005; 31(2):235-46. PubMed ID: 15959450 [TBL] [Abstract][Full Text] [Related]
13. Recovery in remitted first-episode psychosis at 7 years of follow-up of an early dose reduction/discontinuation or maintenance treatment strategy: long-term follow-up of a 2-year randomized clinical trial. Wunderink L; Nieboer RM; Wiersma D; Sytema S; Nienhuis FJ JAMA Psychiatry; 2013 Sep; 70(9):913-20. PubMed ID: 23824214 [TBL] [Abstract][Full Text] [Related]
14. Clinical outcome after antipsychotic treatment discontinuation in functionally recovered first-episode nonaffective psychosis individuals: a 3-year naturalistic follow-up study. Mayoral-van Son J; de la Foz VO; Martinez-Garcia O; Moreno T; Parrilla-Escobar M; Valdizan EM; Crespo-Facorro B J Clin Psychiatry; 2016 Apr; 77(4):492-500. PubMed ID: 26759992 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of LAI in first episode psychosis: an observational study--clinical reports. Cervone A; D'Onghia A; Ferrara M; Massaro CR Psychiatr Danub; 2015 Sep; 27 Suppl 1():S348-52. PubMed ID: 26417794 [TBL] [Abstract][Full Text] [Related]
16. Clozapine use in early psychosis. Thien K; Bowtell M; Eaton S; Bardell-Williams M; Downey L; Ratheesh A; McGorry P; O'Donoghue B Schizophr Res; 2018 Sep; 199():374-379. PubMed ID: 29525463 [TBL] [Abstract][Full Text] [Related]
17. Effect of discontinuation v. maintenance of antipsychotic medication on relapse rates in patients with remitted/stable first-episode psychosis: a meta-analysis. Kishi T; Ikuta T; Matsui Y; Inada K; Matsuda Y; Mishima K; Iwata N Psychol Med; 2019 Apr; 49(5):772-779. PubMed ID: 29909790 [TBL] [Abstract][Full Text] [Related]
18. A review of second-generation antipsychotic discontinuation in first-episode psychosis. Miller BJ J Psychiatr Pract; 2008 Sep; 14(5):289-300. PubMed ID: 18832960 [TBL] [Abstract][Full Text] [Related]
19. Family environment and depressive episode are associated with relapse after first-episode psychosis. da Silva AHS; de Freitas LA; Shuhama R; Del-Ben CM; Vedana KGG; Martin IDS; Zanetti ACG J Psychiatr Ment Health Nurs; 2021 Dec; 28(6):1065-1078. PubMed ID: 33544947 [TBL] [Abstract][Full Text] [Related]
20. Oral and Palmitate Paliperidone Long-Acting Injectable Formulations' Use in Schizophrenia Spectrum Disorders: A Retrospective Cohort Study from the First Episode Psychosis Intervention Program (CRUPEP). Segarra R; Recio-Barbero M; Sáenz-Herrero M; Mentxaka O; Cabezas-Garduño J; Eguíluz JI; Callado LF Int J Neuropsychopharmacol; 2021 Sep; 24(9):694-702. PubMed ID: 34009370 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]